Renal thromboembolism during treatment with recombinant activated factor VII (rFVIIa) in a child with hemophilia B with factor IX inhibitors

被引:0
|
作者
Danko Milošević
Ernest Bilić
Danica Batinić
Mirjana Poropat
Ranka Štern-Padovan
Slobodan Galić
Daniel Turudić
机构
[1] Clinical Medical Centre Zagreb,Department of Pediatrics, Division of Nephrology
[2] University of Zagreb School of Medicine,Department of Pediatrics, Division of Hematology and Oncology
[3] Clinical Medical Centre Zagreb,Department of Nuclear Medicine and Radiation Protection
[4] University of Zagreb School of Medicine School of Medicine,Department for Diagnostic and Interventional Radiology
[5] Clinical Medical Centre Zagreb,undefined
[6] University of Zagreb School of Medicine,undefined
[7] Clinical Medical Centre Zagreb,undefined
[8] University of Zagreb School of Medicine,undefined
[9] University of Zagreb School of Medicine,undefined
来源
关键词
Vascular Anomaly; Hemophilia Patient; Novoseven; rFVIIa Administration; Multiple Renal Artery;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Renal thromboembolism during treatment with recombinant activated factor VII (rFVIIa) in a child with hemophilia B with factor IX inhibitors
    Evic, Danko Milo
    Bilic, Ernest
    Batinic, Danica
    Poropat, Mirjana
    tern-Padovan, Ranka
    Galic, Slobodan
    Turudic, Daniel
    [J]. BMC PEDIATRICS, 2014, 14
  • [2] RADIONUCLIDE EVALUATION OF RENAL THROMBOEMBOLIC EVENT DURING TREATMENT WITH RECOMBINANT ACTIVATED FACTOR VII IN A CHILD WITH HAEMOPHILIA B WITH PLASMA IX INHIBITORS
    Spajic, Marija
    Milosevic, Danko
    Batinic, Danica
    Poropat, Mirjana
    Galic, Slobodan
    Turudic, Daniel
    Bilic, Ernest
    [J]. PEDIATRIC NEPHROLOGY, 2015, 30 (09) : 1569 - 1569
  • [3] Activated recombinant factor VII (rFVIIa)
    Grottke, Oliver
    Henzler, Dietrich
    Rossaint, Rolf
    [J]. BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY, 2010, 24 (01) : 95 - 106
  • [4] Home treatment with recombinant factor VIIa (rFVIIa) in hemophilia A or B patients with inhibitors
    Laurian, Y
    Goudemand, J
    Négrier, C
    Vicariot, M
    Marqués-Verdier, A
    Fonlupt, J
    Gaillard, S
    Fressinaud, E
    Dirat, G
    Sultan, Y
    Faradji, A
    Clayessens, S
    Guérois, C
    Peynet, J
    Bertrand, MA
    Digy, JP
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 15 - 15
  • [5] RECOMBINANT ACTIVATED FACTOR-VII (RFVIIA) THERAPY FOR INTRACRANIAL HEMORRHAGE IN HEMOPHILIA-A PATIENTS WITH INHIBITORS
    SCHMIDT, ML
    GAMERMAN, S
    SMITH, HE
    SCOTT, JP
    DIMICHELE, DM
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1994, 47 (01) : 36 - 40
  • [6] Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage
    Brady, Kenneth M.
    Easley, R. Blaine
    Tobias, Joseph D.
    [J]. PEDIATRIC ANESTHESIA, 2006, 16 (10) : 1042 - 1046
  • [7] Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa)
    S. Segal
    I. Y. Shemesh
    R. Blumenthal
    B. Yoffe
    N. Laufer
    Y. Ezra
    I. Levy
    M. Mazor
    U. Martinowitz
    [J]. Archives of Gynecology and Obstetrics, 2003, 268 (4) : 266 - 267
  • [8] Pharmacokinetics of recombinant activated factor VII (rFVIIa)
    Erhardtsen, E
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (04): : 385 - 391
  • [9] The Comparison of Hemostatic Effects of Recombinant Activated Factor VII (rFVIIa) in Thrombocytopenic Patients (pts) and Hemophilia Pts with Inhibitors
    Galstian, Gennadii M.
    Kolosova, Irina V.
    Gemdzhian, Eduard
    Zorenko, Vladimir Yu.
    Polyanskaya, Tatyana A.
    Orel, Elena B.
    Savchenko, Valeri G.
    [J]. BLOOD, 2015, 126 (23)
  • [10] Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
    Aggarwal A.
    Malkovska V.
    Catlett J.P.
    Alcorn K.
    [J]. Thrombosis Journal, 2 (1)